Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.
According to Biogen's latest financial reports the company's current earnings are €9.60 Billion. In 2023 the company made an earning of €1.25 Billion a decrease over its 2022 earnings that were of €3.46 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.